TY - JOUR
T1 - A-to-I RNA Editing
T2 - An Overlooked Source of Cancer Mutations
AU - Ben-Aroya, Shay
AU - Levanon, Erez Y.
N1 - Publisher Copyright:
© 2018
PY - 2018/5/14
Y1 - 2018/5/14
N2 - RNA editing is a source of transcriptomic diversity, mainly in non-coding regions, and is found to be altered in cancer. In this issue of Cancer Cell, Peng et al. show that RNA editing events are manifested at the proteomic levels and are a source of cancer protein heterogeneity. RNA editing is a source of transcriptomic diversity, mainly in non-coding regions, and is found to be altered in cancer. In this issue of Cancer Cell, Peng et al. show that RNA editing events are manifested at the proteomic levels and are a source of cancer protein heterogeneity.
AB - RNA editing is a source of transcriptomic diversity, mainly in non-coding regions, and is found to be altered in cancer. In this issue of Cancer Cell, Peng et al. show that RNA editing events are manifested at the proteomic levels and are a source of cancer protein heterogeneity. RNA editing is a source of transcriptomic diversity, mainly in non-coding regions, and is found to be altered in cancer. In this issue of Cancer Cell, Peng et al. show that RNA editing events are manifested at the proteomic levels and are a source of cancer protein heterogeneity.
UR - http://www.scopus.com/inward/record.url?scp=85046784718&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2018.04.006
DO - 10.1016/j.ccell.2018.04.006
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.shortsurvey???
C2 - 29763617
SN - 1535-6108
VL - 33
SP - 789
EP - 790
JO - Cancer Cell
JF - Cancer Cell
IS - 5
ER -
